AGRX: Agile Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.09
Enterprise Value ($M) 2.43
Book Value ($M) -16.32
Book Value / Share -2.38
Price / Book -0.19
NCAV ($M) -17.04
NCAV / Share -2.49
Price / NCAV -0.18

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.06
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.33
Current Ratio 0.46

Balance Sheet (mrq) ($M)
Current Assets 9.53
Assets 10.26
Liabilities 26.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 19.59
Operating Income -19.88
Net Income -14.46
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -9.58
Cash from Investing 0.00
Cash from Financing 6.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Lind Global Fund II LP 1.80
02-06 13G/A Intracoastal Capital, Llc 0.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 7,050 27,401 25.73
2024-04-29 48,589 72,919 66.63

(click for more detail)

Similar Companies
ADIA – Adia Nutrition, Inc. ADXS – Ayala Pharmaceuticals, Inc.
AFFY – Affymax, Inc. AGTX – Agentix Corp.
AHRO – Authentic Holdings, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Agile Therapeutics